Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Henia, Balter"'
Publikováno v:
European Journal of Hybrid Imaging, Vol 2, Iss 1, Pp 1-16 (2018)
Abstract Background The aim of this study was to prospectively compare the detection rate of 68Ga-PSMA versus 11C-Choline in men with prostate cancer with biochemical recurrence and to demonstrate the added value of a tri-modality PET/CT-MRI system.
Externí odkaz:
https://doaj.org/article/b1a487aca3df432ca46f38b41a168c80
Autor:
Eduardo Savio, Javier Giglio, Victoria Trindade, Omar Garcia, Laura Reyes, Pablo Buccino, Elena Vasilskis, Silvia Hernández, Henia Balter, Patricia Oliver
Publikováno v:
Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde, Vol 3, Iss 4 (2019)
O Centro Uruguaio de Imagem Molecular (CUDIM) é um empreendimento do país que visa atender às necessidades assistenciais de saúde na área da imagem molecular para doenças oncológicas, neurológicas e cardiovasculares, que até sua criação n
Externí odkaz:
https://doaj.org/article/bd803ab6b6374fedb83099d39d1e02c9
Autor:
Cristina Dacoll, Henia Balter, Laura Varela, Gaby Buenavida, Nicolás González, Anaulina Silveira, Henry Cohen
Publikováno v:
Acta Gastroenterológica Latinoamericana, Vol 44, Iss 2, Pp 88-93 (2014)
Introducción. La tasa de erradicación de la infección por H pylori con el tratamiento triple estándar ha descendido en el mundo en los últimos años. La resistencia antibiótica es una de las principales causas de la falla del tratamiento. Méto
Externí odkaz:
https://doaj.org/article/c0ba0b4ae8254b12a3396a9dd9ee0716
Autor:
Victoria Trindade, Henia Balter
Publikováno v:
Current Radiopharmaceuticals
Background: The radiolabelling of receptor-binding peptides for therapy is a challenge since the peptide itself is exposed (during labelling, storage and transport) to radiation-induced damage, directly or indirectly, in aqueous solution. Hence, the
Publikováno v:
European Journal of Hybrid Imaging
European Journal of Hybrid Imaging, Vol 2, Iss 1, Pp 1-16 (2018)
European Journal of Hybrid Imaging, Vol 2, Iss 1, Pp 1-16 (2018)
Background The aim of this study was to prospectively compare the detection rate of 68Ga-PSMA versus 11C-Choline in men with prostate cancer with biochemical recurrence and to demonstrate the added value of a tri-modality PET/CT-MRI system. Methods W
Publikováno v:
Journal of Nuclear Medicine. 57:622-627
622 Objectives Mucosal-associated FDG uptake on PET imaging causes difficulty in interpretation as physiologic uptake can mimic pathology (e.g., carcinoma). An initial retrospective pilot study (unpublished) showed maximum mucosal-associated standard
Autor:
Gaudiano Javier, Henia Balter, Trindade Victoria, Hermida Juan, De Marco Eugenia, Oliver Patricia, Ferrando Rodolfo, Terán Mariella, Rodriguez Graciela, Paolino Andrea
Publikováno v:
Current Radiopharmaceuticals. 9:85-93
Lutetium-177 is an emerging radionuclide due its convenient chemical and nuclear properties. In this paper we describe the development and evaluation in Uruguay of the targeted 177 Lu labelled radiopharmaceuticals EDTMP (for bone pain palliation) and
Autor:
null Mirel Cabrera, null Alejandra Medrano, null Nicole Lecot, null Marcelo Fernandez, null Maria Moreno, null Jose A Chabalgoity, null Juan Pablo Gambini, null Omar Alonso, null Henia Balter, null Pablo Cabral
Publikováno v:
Journal of Analytical Oncology. 2:1-9
Purpose: To study surface technetium labeling of stealth DTPA-Liposomeand to evaluate its potential as a molecular imaging tracer for both normal and melanoma-bearing mice. The radiolabeling yield of liposomes was greater than 90%and showed good chem
Autor:
María Di Pace, Xavier Calvet, Ximena Pazos, Jordi Sánchez-Delgado, Henry Cohen, Henia Balter, Cristina Dacoll, Gabriela Sandoya
Publikováno v:
Gastroenterologia y hepatologia. 40(7)
Background Strong acid inhibition increases cure rates with triple therapy and 14-day are more effective than 7-day treatments. The combination of amoxicillin plus metronidazole at full doses has been shown to overcome metronidazole resistance and to
Autor:
Henia Balter, Pablo Cabral, Susan L. Deutscher, Arlhee Diaz-Miqueli, Thomas P. Quinn, Marcelo Fernández, Xiuli Zhang, Normando Iznaga-Escobar, Victoria Calzada
Publikováno v:
Current Radiopharmaceuticals. 5:318-324
In this work Nimotuzumab (monoclonal antibody, recognizes the EGF-R) was radiolabeled with (177)Lu as a potential cancer therapy radiopharmaceutical. In-vitro cell binding studies and in-vivo biodistribution and imaging studies were performed to dete